Long-Term Treatment with Injectable Testosterone Undecanoate (TU) Improves Lipid Profile in Men with Hypogonadism and Type 2 Diabetes in Comparison to an Untreated Control Group: Ten-Year Data from a Urological Registry Study

View our Privacy Policy & Terms of Use

This free content is available to registered users.

Becoming a Registered User only requires your name and email address.

Login    Register Now for Your Free Account